Remote respiratory resistance exercise training improves respiratory function in individuals with VCP multisystem proteinopathy.

• Respiratory failure is a primary cause of mortality in individuals with VCP multisystem. • Respiratory resistance training strengthens inspiratory muscles. • Maximum inspiratory pressure increased significantly by a mean of 0.392cm. H 2 O/week. • Remote respiratory resistance treatments are feasible and successful. Valosin-containing protein (VCP) disease is an autosomal dominant multisystem proteinopathy associated with hereditary inclusion body myopathy, Paget disease of bone, and frontotemporal dementia. Myopathy frequently results in respiratory muscle weakness, leading to early mortality due to respiratory failure. We investigated the effects of a remotely administered inspiratory muscle training program in individuals with VCP disease. Nine adults with VCP mutation-positive familial myopathy without evidence of dementia were recruited for a 40-week remotely administered study. Baseline performance was established during the first 8 weeks, followed by 32 weeks of inspiratory muscle training. The primary outcome was maximum inspiratory pressure (MIP). The secondary and exploratory endpoints included spirometry, grip strength, Inclusion Body Myopathy Functional Rating Scale (IBMFRS), Amyotrophic Lateral Sclerosis Functional Rating Scale (ALSFRS), timed up and go, and six-minute walk test (6MWT). During the treatment phase, MIP increased significantly by a weekly mean of 0.392cm. H 2 O (p =0.023). In contrast, grip strength and ALSFRS significantly decreased by 0.088 lbs. (p =0.031) and 0.043 points (p =0.004) per week, respectively, as expected from the natural progression of this disease. A remotely administered inspiratory muscle training program is therefore feasible, safe, and well-tolerated in individuals with VCP disease and results in improved inspiratory muscle strength. [ABSTRACT FROM AUTHOR]